CTOs on the Move

Revolution Enterprises

www.revolutionenterprises.org

 
Revolution Cannabis is committed to producing the cleanest, most reliable and efficacious medical cannabis products. Our team is comprised of passionate cannabis cultivation, public health, and research professionals united by a desire to cultivate health and happiness through the science of cannabis. Revolution`s core values permeate every facet of operations spanning cultivation, breeding, production, packaging, labeling, community outreach, and more.
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Orthocare Medical Eqp

Orthocare Medical Eqp is a Bedford, NH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Haywood Vocational Opportunities

Haywood Vocational Opportunities is a Hazelwood, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

QMES

QMES, LLC is a rapidly growing Durable Medical Equipment (DME) company. We provide superior customer service 24-hours a day to clients located in nine states in the northeast region of the U.S.

Franz Center For Children

Franz Center For Children is a Orlando, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

HeartBeam

HeartBeam, Inc. (NASDAQ: BEAT) is a development stage digital healthcare company with proprietary ECG telemedicine technology that will redefine the way high risk cardiovascular patients are diagnosed in an ambulatory setting at any time and any place. Its breakthrough solution employs a reusable, credit card sized, 3D vector ECG recording device and cloud-based software capable of assisting a physician in diagnosing a wide range of cardiovascular disease. HeartBeam is initially focusing on a huge unmet need of helping diagnose heart attacks in patients outside of a medical institution. No single lead ECG technology can offer this value to patients and their physicians. This underserved market is several times larger than the cardiac arrhythmia detection market based on the prevalence of patients with coronary artery disease at high risk of heart attack